Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Rodent and early human studies support feasibility of transcutaneous immunization

April 21, 1999

First CpG DNA-based immunotherapeutic enters human trials

April 20, 1999

Potential C. albicans vaccine tested in mice

April 20, 1999

Immune Response describes herpes vaccine research at FASEB 99

April 19, 1999

Compounds and methods for treating or diagnosing leishmaniasis disclosed by Corixa

April 16, 1999

Epimmune publishes studies on hepatitis, malaria vaccine development

April 12, 1999

SangStat's ciclosporin capsules filed for approval in U.K.

April 12, 1999

Fujisawa and NeXstar team up to identify new immunological agents

April 12, 1999

Addition of Canadian sites to phase III WF-10 AIDS trial approved

April 12, 1999

LeIF adjuvant enhances therapeutic efficacy of leishmaniasis vaccine in humans

April 9, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...